Adial Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expenses, Other
Adial Pharmaceuticals, Inc. (ADIL) reported Increase (Decrease) in Prepaid Expenses, Other of -$63.36 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2025-11-13
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-12-31 was -$67.79K.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-09-30 was -$342.32K.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-06-30 was $310.75K.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-03-31 was $36.00K.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$63.36K, a 385.96% decline from fiscal 2023.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was $22.16K.
- Adial Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$9.93K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$67.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$410.11K derived: sum of 2 quarters · filed 2025-11-13 | -$99.36K derived: sum of 3 quarters · filed 2025-11-13 | -$63.36K 10-K · filed 2025-03-04 |
| 2024-09-30 | -$342.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$31.57K derived: sum of 2 quarters · filed 2025-11-13 | $4.43K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $310.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $346.75K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $36.00K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $22.16K 10-K · filed 2025-03-04 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$9.93K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$9.93K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |